ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 690271 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 690271; 2) Community: the network communities that were significantly associated with the response to NSC 690271; 3) Molecule: the relationships between components within communities and NSC 690271; 4) MDR: the compounds that were significantly associated with the NSC 690271.

NSC Compound Enrichment Correlation
NSC 750054 3-(3,7-dimethyl-1,4-dioxyquinoxalin-2-yl)-1-(3,4,5-trimethoxyphenyl)-propenone 0.0115521552688257 0.39468744
NSC 751393 2-(4,5-dibenzoyl-1,3-dithiol-2-ylidene)-1-ethyl-6-(phenylimino)-3-thioxo-2,3-dihydro-1H-thieno[2,3-b][1,4]thiazin-7(6H)-one 0.0115521552688257 0.40708578
NSC 757113 METHOTREXATE(+/-) 0.0115521552688257 0.33337865
NSC 95448 1H-1,2,4-Triazole, 3-(4-diazo-4H-imidazol-5-yl)- 0.0115521552688257 0.55555608
NSC 9706 Triethylenemelamine 0.0115521552688257 0.67596942
NSC 112758 Rubomycin 0.0115521552688258 0.3933895
NSC 112846 N-[p-[[(2,4-Diamino-6-quinazolinyl)methyl]amino]benzoyl]-L-aspartic acid 0.0115521552688258 0.27082771
NSC 282159 EN 589 0.0115521552688258 0.40459131
NSC 628562 4H-1,3,2-Benzodioxastannin-4-one, 7-amino-2,2-diphenyl- 0.0115521552688258 0.36063531
NSC 633497 Null 0.0115521552688258 0.38619065
Total:100  Current:33    [First] [Prev] [Next] [Last]